Collaborative Agreements |
12 Months Ended |
---|---|
Dec. 31, 2023 | |
Collaborative Agreements [Abstract] | |
COLLABORATIVE AGREEMENTS | NOTE 11 – COLLABORATIVE AGREEMENTS
During September 2020, the Company was awarded a grant of up to $2.9 million from the National Institutes of Health (“NIH”). The grant will support a Phase 2 study of XPro in patients with treatment resistant depression. As of December 31, 2023, the Company has not received any proceeds pursuant to this grant. |